This inventor holds 2 USPTO granted patents. Top assignees: Laboratoires Jacques Logeais, Laboratories Jacques Logeais. Active years: 1993-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1998
Title: Thierry Bouyssou: Innovator in Gastrointestinal Treatments
Introduction
Thierry Bouyssou is a notable inventor based in Plaisir, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bowel disorders. With a focus on innovative compounds, Bouyssou has secured a total of 2 patents throughout his career.
Latest Patents
His latest patents include the use of N-cyclohexyl benzamides for treating bowel disorders. This involves cyclohexylbenzamide derivatives, their preparations, and their use as powerful gastrointestinal motility stimulants. The compounds he has developed are characterized by a specific formula where R1 represents an alkoxy radical capable of cyclizing with the aromatic ring, while R2, R3, and R4 can represent various groups, including hydrogen, halogen, or alkoxy. Additionally, Z represents a differently substituted piperidinyl group, along with their addition salts with pharmaceutically acceptable acids.
Career Highlights
Throughout his career, Bouyssou has worked with Laboratories Jacques Logeais, where he has contributed to the development of innovative pharmaceutical solutions. His work has focused on creating effective treatments that enhance gastrointestinal motility.
Collaborations
He has collaborated with notable professionals in the field, including Helene Christinaki and Alain J Renaud. These collaborations have further enriched his research and development efforts.
Conclusion
Thierry Bouyssou's contributions to the pharmaceutical industry, particularly in gastrointestinal treatments, highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to advancing medical science through novel compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile